Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation
Why the study?
Does percutaneous left atrial appendage transcatheter occlusion prevent stroke in high-risk patients with atrial fibrillation?
Structured PICO
Does percutaneous left atrial appendage transcatheter occlusion prevent stroke in high-risk patients with atrial fibrillation?
P
Population
High-risk patients with atrial fibrillation who are not suitable candidates for anticoagulation therapy
I
Intervention
Percutaneous left atrial appendage (LAA) transcatheter occlusion
O
Outcome
Feasibility of transcatheter closure of the LAA and stroke prevention
Transcatheter closure of the left atrial appendage is a feasible novel implant technology for patients with atrial fibrillation who are unsuitable for anticoagulation.
Limitations
- Further trials are needed to show long-term safety and efficacy in reducing stroke
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Feasibility of transcatheter LAA closure in humans supports device development; leaves open stroke prevention efficacy versus anticoagulation in AF.
Cite This Study
Sievert et al. (2002) studied this question.